BRAF and Langerhans cell histiocytosis: A series of studies confirmed that LCH can harbor a BRAF V600E mutation, other activating mutations in the MAPK-extracellular signal-regulated kinase (MAPK–ERK) pathway, and kinase fusions [26–28].